Dan Atar

Q: What Schools Are Affiliated With Dan Atar

Dan Atar is affiliated with the following schools: University of Oslo, Medical University of Vienna, University of Bergen, Queen's University at Kingston, Lund University, Ben-Gurion University of the Negev, Johns Hopkins University

Dan Atar's AcademicInfluence.com Rankings

Dan Atar

Medical

#959

World Rank

#1235

Historical Rank

Cardiology

#86

World Rank

#87

Historical Rank

medical Degrees

Dan Atar

Philosophy

#5532

World Rank

#8360

Historical Rank

Logic

#2795

World Rank

#3838

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Why Is Dan Atar Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Dan Atar is a clinical cardiologist, researcher and professor. He is head of research at Oslo University Hospital, Div. of Medicine, and a full professor at the Institute of Clinical Sciences of the University of Oslo, Norway. He is Editor-in- Chief of the scientific journal Cardiology.

(See a Problem?)

Dan Atar's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. (2012) (7528)
Apixaban versus warfarin in patients with atrial fibrillation. (2011) (6217)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (2016) (4929)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (2016) (4672)
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). (2010) (4221)
Third universal definition of myocardial infarction. (2012) (4123)
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. (2012) (3704)
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). (2010) (3518)
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. (2012) (3356)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (2016) (2451)
2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS. (2017) (1930)
Recombinant Human Bone Morphogenetic Protein-2 for Treatment of Open Tibial Fractures: A Prospective, Controlled, Randomized Study of Four Hundred and Fifty Patients (2002) (1296)
Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) (2007) (1141)
Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts) (2007) (1040)
European guidelines on cardiovascular disease prevention in clinical practice: executive summary. (2007) (965)
Third universal definition of myocardial infarction. (2012) (921)
European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invit (2007) (911)
Apixaban with antiplatelet therapy after acute coronary syndrome. (2011) (872)
European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invit (2007) (869)
European guidelines on cardiovascular disease prevention in clinical practice: full text (2005) (840)
Third universal definition of myocardial infarction. (2012) (751)
ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. (2016) (603)
Corrigendum to: ‘Guidelines for the management of atrial fibrillation’ [European Heart Journal (2010) 31, 2369–2429 and EP-Europace (2010) 12, 1360–1420] (2011) (570)
Effect of nesiritide in patients with acute decompensated heart failure. (2011) (516)
Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. (2014) (422)
Role of troponin I proteolysis in the pathogenesis of stunned myocardium. (1997) (416)
EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE (ENDING). FOURTH JOINT TASK FORCE OF THE EUROPEAN SOCIETY OF CARDIOLOGY AND OTHER SOCIETIES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE (2004) (412)
Dronedarone in high-risk permanent atrial fibrillation. (2011) (368)
Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. (2011) (364)
Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial (2014) (312)
A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry. (2014) (306)
Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients. (2014) (256)
Angiotensin Receptor Neprilysin Inhibitor LCZ696 Attenuates Cardiac Remodeling and Dysfunction After Myocardial Infarction by Reducing Cardiac Fibrosis and Hypertrophy (2015) (248)
Relationship between intracellular calcium and contractile force in stunned myocardium. Direct evidence for decreased myofilament Ca2+ responsiveness and altered diastolic function in intact ventricular muscle. (1995) (238)
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. (2021) (238)
Excitation-Transcription Coupling Mediated by Zinc Influx through Voltage-dependent Calcium Channels (*) (1995) (227)
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation (2016) (220)
Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study. (2007) (210)
Corrigendum to ‘ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008’ [Eur Heart J 2008;29:2388–2442 and Eur J Heart Fail 2008;10:933–989] (2009) (208)
Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial. (2014) (179)
Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy. (2013) (177)
Gender differences in the effects of cardiovascular drugs (2017) (171)
Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results. (2015) (168)
Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial. (2009) (164)
Distinct subcellular localization of calcium binding S100 proteins in human smooth muscle cells and their relocation in response to rises in intracellular calcium. (1998) (160)
Frequency and significance of troponin T elevation in acute ischemic stroke. (2007) (160)
High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin. (2014) (148)
N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis. (2007) (145)
Tumor Necrosis Factor-&agr; Antagonists Improve Aortic Stiffness in Patients With Inflammatory Arthropathies: A Controlled Study (2010) (141)
Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study. (2012) (141)
APPRAISE 2. Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome for the APPRAISE-2 Investigators* (2011) (136)
Cardiac Troponin I Is Modified in the Myocardium of Bypass Patients (2001) (128)
[Pregnancy-associated osteoporosis]. (1996) (127)
Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure. (2013) (125)
Androgenic anabolic steroid abuse and the cardiovascular system. (2010) (123)
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. (2016) (119)
The Ilizarov technique in correction of complex foot deformities. (1992) (119)
Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study (2011) (118)
How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure? (2004) (115)
Guidelines for the management of atrial fibrillation (Europace (2010) 12, (1360-1420)) (2011) (111)
Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial (2018) (110)
Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trials (2003) (109)
High-Sensitivity Troponin I for Risk Assessment in Patients With Atrial Fibrillation: Insights From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial (2013) (109)
Troponin I in acute decompensated heart failure: insights from the ASCEND‐HF study (2011) (103)
‘2012 focused update of the ESC Guidelines for the management of atrial fibrillation’ [Eur Heart J (2012); 33(21):2719–2747] (2013) (103)
[2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS]. (2016) (101)
Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference (2018) (94)
Mechanism of troponin elevations in patients with acute ischemic stroke. (2007) (91)
Guía ESC 2016 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración con la EACTS (2017) (86)
Hyperkalaemia and impaired renal function in patients taking spironolactone for congestive heart failure: retrospective study (2003) (83)
Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial. (2015) (82)
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1. (2016) (81)
Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial. (2014) (81)
Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial. (2017) (80)
[Fourth universal definition of myocardial infarction (2018)]. (2018) (78)
Association of platelet responsiveness with clopidogrel metabolism: role of compliance in the assessment of "resistance". (2009) (77)
Assessment of bleeding events in clinical trials--proposal of a new classification. (2007) (76)
Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High‐Risk Myocardial Infarction Database Initiative (2015) (76)
COPD predicts mortality in HF: the Norwegian Heart Failure Registry. (2010) (75)
Percutaneous epiphysiodesis. (1991) (73)
Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin (2003) (72)
Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency (2016) (71)
Complications in clubfoot surgery. (1991) (69)
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. (2022) (68)
A new automatic algorithm for quantification of myocardial infarction imaged by late gadolinium enhancement cardiovascular magnetic resonance: experimental validation and comparison to expert delineations in multi-center, multi-vendor patient data (2016) (68)
Wytyczne ESC dotyczące leczenia migotania przedsionków w 2016 roku, opracowane we współpracy z EACTS (2016) (68)
Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study (2007) (67)
The myth of ‘stable’ coronary artery disease (2019) (67)
Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology. (2016) (65)
Bleeding risks of combination vs. single antiplatelet therapy: a meta‐analysis of 18 randomized trials comprising 129 314 patients (2008) (63)
Early measurements of plasma matrix metalloproteinase-2 predict infarct size and ventricular dysfunction in ST-elevation myocardial infarction (2011) (63)
Hard tissue remodeling using biofabricated coralline biomaterials. (2002) (62)
‘Treat to target’: moving targets from hypertension, hyperlipidaemia and diabetes to rheumatoid arthritis (2010) (62)
Current role of neprilysin inhibitors in hypertension and heart failure. (2014) (61)
Prevalence of impaired left ventricular systolic function and heart failure in a middle aged and elderly urban population segment of Copenhagen (2003) (59)
Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation myocardial infarction. (2009) (59)
The Effects of Climate Change on Cardiac Health (2015) (59)
Correlation of inhibition of platelet aggregation after clopidogrel with post discharge bleeding events: assessment by different bleeding classifications. (2010) (59)
Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight. (2019) (59)
Extensive Troponin I and T Modification Detected in Serum From Patients With Acute Myocardial Infarction (2000) (58)
Fatty Acid Binding Protein 4 Is Associated with Carotid Atherosclerosis and Outcome in Patients with Acute Ischemic Stroke (2011) (55)
Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management—a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology (2015) (54)
Guías de práctica clínica para el manejo de la fibrilación auricular (2010) (53)
Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis (2018) (53)
Oxygen therapy in acute coronary syndrome: are the benefits worth the risk? (2013) (52)
Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trial. (2015) (52)
Effect of a single dose aspirin on platelets in humans with multiple risk factors for coronary artery disease. (2003) (51)
Corrigendum to: ‘2012 focused update of the ESC Guidelines for the management of atrial fibrillation’ [Eur Heart J (2012); 33(21):2719–2747] (2013) (51)
Increased soluble platelet / endothelial cellular adhesion molecule‐1 and osteonectin levels in patients with severe congestive heart failure. Independence of disease etiology, and antecedent aspirin therapy (1999) (50)
Guía de práctica clínica de la sociedad europea de cardiología (ESC) para el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica (2008) (2008) (50)
Early Prediction of Increased Arterial Stiffness in Patients with Chronic Inflammation: A 15-year Followup Study of 108 Patients with Rheumatoid Arthritis (2011) (50)
Multi-vendor, multicentre comparison of contrast-enhanced SSFP and T2-STIR CMR for determining myocardium at risk in ST-elevation myocardial infarction (2016) (49)
Time Course of Degradation of Cardiac Troponin I in Patients With Acute ST-Elevation Myocardial Infarction: The ASSENT-2 Troponin Substudy (2006) (48)
Predictors of early dyspnoea relief in acute heart failure and the association with 30‐day outcomes: findings from ASCEND‐HF (2013) (48)
Increased heart rate variability during nondirective meditation (2012) (47)
Aspirin inhibits surface glycoprotein IIb/IIIa, P‐selectin, CD63, and CD107a receptor expression on human platelets (2003) (47)
Heat Stress Impacts on Cardiac Mortality in Nepali Migrant Workers in Qatar (2019) (47)
An integrated approach to diagnosis and therapeutic management of patients with systolic heart failure in the Copenhagen metropolitan area. (2002) (47)
Osteoprotegerin concentrations and prognosis in acute ischaemic stroke (2010) (47)
Determinants and prognostic implications of Cardiac Troponin T measured by a sensitive assay in Type 2 Diabetes Mellitus (2010) (45)
Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry. (2015) (44)
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. (2016) (44)
The association between disease activity and NT-proBNP in 238 patients with rheumatoid arthritis: a 10-year longitudinal study (2008) (43)
Cardiac troponin I for the prediction of functional recovery and left ventricular remodelling following primary percutaneous coronary intervention for ST-elevation myocardial infarction (2010) (43)
Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial. (2004) (42)
Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial. (2015) (41)
Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudy. (2015) (41)
Alterations of excitation-contraction coupling in stunned myocardium and in failing myocardium. (1995) (41)
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke. (2019) (41)
Rationale and Design of the 'MITOCARE' Study: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of TRO40303 for the Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction (2012) (40)
The cancer patient and cardiology (2020) (39)
The heart failure burden of type 2 diabetes mellitus—a review of pathophysiology and interventions (2018) (39)
Evaluation of dyspnoea in a sample of elderly subjects recruited from general practice (2007) (37)
Is there a need for lumbar orthosis in mild compression fractures of the thoracolumbar spine?: A retrospective study comparing the radiographic results between early ambulation with and without lumbar orthosis. (2000) (36)
Revision surgery in clubfeet. (1992) (36)
Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy. (2004) (36)
NT-proBNP predicts mortality in patients with rheumatoid arthritis: results from 10-year follow-up of the EURIDISS study (2010) (36)
Viewpoint: Central adjudication of myocardial infarction in outcome-driven clinical trials – Common patterns in TRITON, RECORD, and PLATO? (2012) (36)
Guías de práctica clínica sobre prevención de la enfermedad cardiovascular: Versión resumida (2008) (36)
Randomized evaluation of beta blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): Rationale and design. (2020) (35)
Pediatric Olecranon Fractures: Open Reduction and Internal Fixation With Removable Kirschner Wires and Absorbable Sutures (2006) (35)
Neurohormonal Blockade in Heart Failure. (2016) (35)
Sample Size in Clinical Cardioprotection Trials Using Myocardial Salvage Index, Infarct Size, or Biochemical Markers as Endpoint (2016) (34)
Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. (2015) (34)
Ilizarov Technique in Correction of Foot Deformities: A Preliminary Report (1990) (34)
Patients with metabolic syndrome exhibit higher platelet activity than those with conventional risk factors for vascular disease (2008) (34)
Soluble CXCL16 and long-term outcome in acute ischemic stroke. (2012) (33)
Whole blood impedance aggregometry for the assessment of platelet function in patients with congestive heart failure (EPCOT Trial) (2002) (33)
Prevalence of diastolic dysfunction as a possible cause of dyspnea in the elderly. (2005) (33)
Dyspnoea after antiplatelet agents: the AZD6140 controversy (2007) (33)
Congenital Pseudoarthrosis of the Tibia (2000) (32)
Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry (2019) (32)
Treatment of complex limb deformities in children with the Ilizarov technique. (1991) (32)
Early Impact of Prescription Omega-3 Fatty Acids on Platelet Biomarkers in Patients with Coronary Artery Disease and Hypertriglyceridemia (2011) (32)
Pregnancy-associated osteoporosis: preliminary densitometric evidence of extremely rapid recovery of bone mineral density. (1998) (32)
Pathophysiology, Diagnosis, and Management of the No-Reflow Phenomenon (2019) (31)
Effects of Magnesium Supplementation in a Porcine Model of Myocardial Ischemia and Reperfusion (1994) (31)
Escitalopram, but Not Its Major Metabolites, Exhibits Antiplatelet Activity in Humans (2006) (31)
Tolerability of β-Blocker Initiation and Titration with Bisoprolol and Carvedilol in Congestive Heart Failure – A Randomized Comparison (2004) (31)
Time-resolved tracking of the atrioventricular plane displacement in Cardiovascular Magnetic Resonance (CMR) images (2017) (31)
ESC guidelines adherence is associated with improved survival in patients from the Norwegian Heart Failure Registry. (2015) (30)
Guía de práctica clínica de la ESC para el manejo del infarto agudo de miocardio en pacientes con elevación del segmento ST (2013) (30)
FDA and CPMP Rulings on Subgroup Analyses (2006) (29)
Health Care Professionals’ Perceptions of Home Telemonitoring in Heart Failure Care: Cross-Sectional Survey (2019) (29)
Combined angiotensin receptor blockade and neprilysin inhibition attenuates angiotensin-II mediated renal cellular collagen synthesis. (2015) (29)
Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure (2017) (29)
Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease (2022) (29)
Usefulness of natriuretic peptide testing for long-term risk assessment following acute ischemic stroke. (2009) (28)
Inter-patient variability and impact of proton pump inhibitors on platelet reactivity after prasugrel (2011) (28)
Pharmacological conversion of recent-onset atrial fibrillation: A systematic review (2013) (28)
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry (2018) (27)
Carpal canal stenosis in men with idiopathic carpal tunnel syndrome. (1992) (27)
New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention? (2021) (26)
Comorbidities and polypharmacy. (2014) (26)
European Stroke Organisation (ESO) (2008) (26)
ESC Core Curriculum for the Cardiologist. (2020) (26)
Reduced Concentrations of Soluble Adhesion Molecules after Antioxidant Supplementation in Postmenopausal Women with High Cardiovascular Risk Profiles – A Randomized Double-Blind Study (2001) (26)
Gender differences among Norwegian patients with heart failure. (2011) (26)
Dobutamine Stress Echocardiography to Detect Inducible Demand Ischemia in Anesthetized Patients with Coronary Artery Disease (1998) (26)
Activated Leukocyte Cell Adhesion Molecule and Prognosis in Acute Ischemic Stroke (2011) (26)
The L-arginine/asymmetric dimethylarginine ratio is improved by anti-tumor necrosis factor-α therapy in inflammatory arthropathies. Associations with aortic stiffness. (2012) (25)
Antiplatelet Properties of Escitalopram in Patients with the Metabolic Syndrome: A Dose-Ranging In Vitro Study (2007) (25)
The PLATO trial: do you believe in magic? (2010) (25)
ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation (2013) (24)
Noncompliance in cardiovascular clinical trials. (2005) (24)
Clinical review: Impact of statin substitution policies on patient outcomes (2009) (24)
Preventing and overcoming equinus contractures during lengthening of the tibia. (1991) (23)
Diuretic Use in Heart Failure and Outcomes (2013) (23)
'Ten Commandments' of 2016 ESC Guidelines for the management of atrial fibrillation. (2016) (23)
Magnesium and myocardial infarction (1994) (23)
Magnesium deficiency prolongs myocardial stunning in an open-chest swine model. (1994) (23)
Incremental value of a combination of cardiac troponin T, N-terminal pro-brain natriuretic peptide and C-reactive protein for prediction of mortality in end-stage renal disease (2011) (23)
Pavlik Harness Versus Frejka Splint in Treatment of Developmental Dysplasia of the Hip: Bicenter Study (1993) (23)
Antithrombotic Therapy and Major Adverse Limb Events in Patients With Chronic Lower Extremity Arterial Disease: Systematic Review and Meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working (2019) (22)
The use of a tissue expander in club-foot surgery. A case report and review. (1990) (22)
Corrigendum to ‘ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008’ [Eur Heart J 2008;29:2388–2442 and Eur J Heart Fail 2008;10:933–989] (2008) (22)
Results of complete soft tissue clubfoot release combined with calcaneocuboid fusion in the 4-year to 8-year age group following failed clubfoot release. (1999) (22)
Lack of nuclear apoptosis in cardiomyocytes and increased endothelin-1 levels in a rat heart model of myocardial stunning (2000) (21)
Changes in oral anticoagulation for elective cardioversion: results from a European cardioversion registry (2017) (21)
Carvedilol Compared With Metoprolol Succinate in the Treatment and Prognosis of Patients With Stable Chronic Heart Failure: Carvedilol or Metoprolol Evaluation Study (2015) (20)
Changes in arterial stiffness during continued infliximab treatment in patients with inflammatory arthropathies (2011) (20)
Use of Tissue Expansion in Clubfoot Surgery (1993) (20)
Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes. (2013) (20)
A Critical Appraisal of the Phenomenon of Aspirin Resistance (2005) (20)
Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction. (2018) (20)
Performance of the European Society of Cardiology 0/1-Hour, 0/2-Hour, and 0/3-Hour Algorithms for Rapid Triage of Acute Myocardial Infarction (2021) (20)
Isolation, electron microscopic imaging, and 3-D visualization of native cardiac thin myofilaments. (1999) (20)
Pin care using the Ilizarov apparatus: recommended treatment plan in Kurgan, Russia. (1992) (20)
Bilateral hypoplastic lateral meniscus. (1995) (19)
Should oxygen be given in myocardial infarction? (2010) (19)
Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or Warfarin (2017) (19)
Tips of the trade. Computerized tomography--guided excision of osteoid osteoma. (1992) (19)
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials. (2017) (19)
ePoster Sessions (2019) (18)
Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe (2019) (18)
Re-do clubfoot: surgical approach and long-term results. (1990) (18)
Echocardiographic indices of left ventricular diastolic dysfunction in 647 individuals with preserved left ventricular systolic function (2004) (18)
Rationale and Design of the ‘F.I.R.E.’ Study (2006) (18)
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1. (2017) (18)
Guías de práctica clínica sobre prevención de la enfermedad cardiovascular. Versión corregida 22/07/2009 (2008) (17)
Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials (2020) (17)
Patient engagement. (2017) (17)
Effects of in vitro exposure of alcohol on surface receptor expression of human platelets (2002) (17)
Coenzyme Q10 protects ischemic myocardium in an open-chest swine model (2004) (17)
BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study (2019) (16)
Femoral varus derotational osteotomy in cerebral palsy. (1995) (16)
The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events (2019) (16)
Dipyridamole Decreases Protease-Activated Receptor and Annexin-V Binding on Platelets of Poststroke Patients with Aspirin Nonresponsiveness (2006) (16)
Reduced preload elicits increased LV twist in healthy humans (2011) (16)
Pediatric update #14. Functional rating system for evaluating the results of clubfoot surgery. (1990) (15)
Extent of Myocardium at Risk for Left Anterior Descending Artery, Right Coronary Artery, and Left Circumflex Artery Occlusion Depicted by Contrast-Enhanced Steady State Free Precession and T2-Weighted Short Tau Inversion Recovery Magnetic Resonance Imaging (2016) (15)
Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial (2020) (15)
Pathophysiology and therapeutic modification of thrombin generation in patients with coronary artery disease. (2000) (14)
Pediatric update #12. A simplified method for percutaneous epiphysiodesis. (1990) (14)
GARFIELD-AF: a worldwide prospective registry of patients with atrial fibrillation at risk of stroke. (2020) (14)
Influence of ST-segment recovery on infarct size and ejection fraction in patients with ST-segment elevation myocardial infarction receiving primary percutaneous coronary intervention. (2010) (14)
B-type natriuretic peptide trumps other prognostic markers in patients assessed for coronary disease (2019) (14)
Influence of receptor selectivity on benefits from SGLT2 inhibitors in patients with heart failure: a systematic review and head-to-head comparative efficacy network meta-analysis (2021) (14)
Maximizing scientific knowledge from randomized clinical trials. (2010) (14)
Effect of distal hamstring release on cerebral palsy patients. (1993) (14)
Combined hip surgery in cerebral palsy patients. (1995) (14)
Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome (2015) (13)
New definition of myocardial infarction (2008) (13)
The Ilizarov apparatus for treatment of melorheostosis. Case report and review of the literature. (1992) (13)
Noninvasive coronary angiography with 64-channel multidetector computed tomography in patients with acute coronary syndrome (2008) (13)
Revision surgery in clubfeet. (1990) (13)
Self-Care Monitoring of Heart Failure Symptoms and Lung Impedance at Home Following Hospital Discharge: Longitudinal Study (2020) (13)
Fluorimetric quantitation of citalopram and escitalopram in plasma: developing an express method to monitor compliance in clinical trials (2007) (13)
Amyotrophic lateral sclerosis (ALS), a novel rare cause of elevated plasma troponin T levels. (2011) (12)
Ilizarov Technique in Treatment of Congenital Hand Anomalies Two Case Reports (1991) (12)
Calcaneocuboid arthrodesis for recurrent clubfeet: what is the outcome at 17-year follow-up? (2014) (12)
[Treatment of congestive heart failure]. (2007) (12)
Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry (2021) (12)
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention (2017) (12)
Impact of time to therapy and presence of collaterals on the efficacy of FX06 in acute ST elevation myocardial infarction: a substudy of the F.I.R.E., the Efficacy of FX06 in the prevention of myocardial reperfusion injury trial. (2010) (12)
Gender differences in association between uric acid and all-cause mortality in patients with chronic heart failure (2019) (12)
Bilateral simultaneous rupture of the quadriceps tendon in an adult amateur tennis player. (2006) (12)
Biomarkers Associated with Atrial Fibrillation in Patients with Ischemic Stroke: A Pilot Study from the NOR-FIB Study (2020) (11)
Fractional lengthening of the flexor tendons in clubfoot surgery. (1991) (11)
Noncompliance in antiplatelet trials: the AGATE trial perspective. (2004) (11)
Baseline platelet aggregation and major receptor expression predict subsequent activity following thrombolysis for acute myocardial infarction. (2000) (11)
[Arthroscopic treatment for osteoarthritic knee]. (2008) (11)
Minor Knee Trauma As a Possible Cause of Asymmetrical Proximal Tibia1 Physis Closure: A Case Report (1994) (11)
Assessment of coronary artery stenosis pressure gradient by quantitative coronary arteriography in patients with coronary artery disease. (1994) (11)
Functional Rating System for Evaluation of Long-Term Results of Clubfoot Surgery (1994) (11)
Comparison of four different cardiac troponin assays in patients with end-stage renal disease on chronic haemodialysis (2008) (11)
2016 ESC guidelines for the diagnosis and treatment of atrial fibrillation developed in collaboration with the EACTS (2017) (11)
Effects of aliskiren, a renin inhibitor, on biomarkers of platelet activity, coagulation and fibrinolysis in subjects with multiple risk factors for vascular disease (2008) (11)
Consistent platelet inhibition during long-term maintenance-dose clopidogrel therapy among 359 compliant outpatients with documented vascular disease. (2007) (11)
Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis. (2019) (10)
Automatic segmentation of myocardium at risk from contrast enhanced SSFP CMR: validation against expert readers and SPECT (2016) (10)
Carnitine — from cellular mechanisms to potential clinical applications in heart disease (1997) (10)
Tarsal navicular position after complete soft-tissue clubfoot release. (1993) (10)
New oral anticoagulants--a review. (2013) (10)
Atrial fibrillation in cryptogenic stroke and transient ischaemic attack – The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Rationale and design (2019) (10)
EFFICACY AND SAFETY OF APIXABAN COMPARED WITH WARFARIN ACCORDING TO AGE FOR STROKE PREVENTION IN ATRIAL FIBRILLATION (2013) (10)
Atrial Fibrillation and Stroke in Patients with Hypertrophic Cardiomyopathy: Important New Insights (2019) (10)
Cannulated blade plate for proximal femoral varus osteotomy. (1990) (10)
The llizarov apparatus for treatment of melorheostosis (1990) (10)
Greenstick fractures of distal radius followed-up by ultrasound : A prospective study (2000) (9)
Cardiac Troponin I Degradation in Serum of Patients with Hypertrophic Obstructive Cardiomyopathy Undergoing Percutaneous Septal Ablation (2009) (9)
Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study (2018) (9)
Expanding the Evidence Base: Comparing Randomized Controlled Trials and Observational Studies of Statins. (2015) (9)
[Hyperbaric oxygen therapy for chronic diabetic wounds of the lower limbs--a review of the literature]. (2007) (9)
2-D and 3-D computed tomography and magnetic resonance imaging in developmental dysplasia of the hip. (1992) (9)
Atrioventricular plane motion during dobutamine-atropine stress echocardiography: the biphasic response in healthy subjects revisited. (2000) (9)
New-Onset Atrial Fibrillation in Bacteremia Is Not Associated with C-Reactive Protein, but Is an Indicator of Increased Mortality during Hospitalization (2008) (9)
The association between meteorological events and acute heart failure: new insights from ASCEND-HF. (2014) (9)
Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction: a propensity score-matched cohort study (2013) (9)
Increased LV apical untwist during preload reduction in healthy humans: an echocardiographic speckle tracking study during lower body negative pressure (2015) (9)
[Clinical and genetic aspects of congenital insensitivity to pain with anhidrosis]. (2005) (9)
Bilateral dislocation of the hip during convulsions: a case report. (1997) (9)
Cost-Minimization Analysis for Cardiac Revascularization in 12 Health Care Systems Based on the EuroCMR/SPINS Registries. (2021) (9)
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry (2018) (8)
Effects of escalating doses of tirofiban on platelet aggregation and major receptor expression in diabetic patients: hitting the TARGET in the TENACITY trial? (2007) (8)
Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction. (2022) (8)
Incidence and causes of new-onset dyspnea in 3,719 patients treated with clopidogrel and aspirin combination after coronary stenting (2008) (8)
Comparison of methods of fractional area change for detection of regional left ventricular dysfunction (2000) (8)
Treatment of Failed Clubfoot Surgery (1994) (8)
Morphine in myocardial infarction: balancing on the tight rope. (2016) (8)
Outcomes in newly diagnosed atrial fibrillation and history of acute coronary syndromes: insights from GARFIELD-AF. (2019) (8)
Cost Effectiveness of Drug-Eluting Stents as Compared With Bare Metal Stents in Patients With Coronary Artery Disease (2013) (8)
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry (2018) (8)
Mortality and adverse events with brand and generic clopidogrel in the Food and Drug Administration Adverse Event Reporting System (FAERS). (2018) (8)
Surgical technique for an 'almost' percutaneous triple pelvic osteotomy for femoral head coverage in children 6-14 years of age. (2004) (8)
Effect of magnesium sulphate infusion on ex vivo platelet aggregation in swine. (1993) (8)
Highlights of talipes equinovarus deformity. (1995) (8)
Anticoagulants for secondary prevention after acute myocardial infarction: lessons from the past decade (2014) (8)
Complete soft-tissue clubfoot release with and without internal fixation. (1993) (8)
New approach to limb deformities in neuromuscular patients. (1990) (8)
Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fraction (2022) (8)
Intermetatarsal synostosis after treatment with Ilizarov apparatus: a case report. (1992) (7)
The relation between electrocardiographic ST-T changes and NT-proBNP in patients with acute ischemic stroke (2007) (7)
[Molecular modifications of troponin I and T detected in serum from patients with acute myocardial infarction]. (2003) (7)
Do We Need Potent Intravenous Antiplatelet Inhibition at the Time of Reperfusion During ST-Segment Elevation Myocardial Infarction? (2019) (7)
Changes in hemostasis after parenteral magnesium in myocardial ischemia-reperfusion: from animal studies to clinical trials. (1998) (7)
Linee guida ESC per la diagnosi e il trattamento dello scompenso cardiaco acuto e cronico 2008 = Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 (2009) (7)
Longitudinal left ventricular function is globally depressed within a week of STEMI (2018) (7)
Combination Antiplatelet Therapy with Aspirin and Clopidogrel: The Role of Antecedent and Concomitant Doses of Aspirin (2007) (7)
The significance of ST‐elevation in aVL in anterolateral myocardial infarction: An assessment by cardiac magnetic resonance imaging (2018) (7)
Rationale and design of the 'F.I.R.E.' study. A multicenter, double-blind, randomized, placebo-controlled study to measure the effect of FX06 (a fibrin-derived peptide Bbeta(15-42)) on ischemia-reperfusion injury in patients with acute myocardial infarction undergoing primary percutaneous coronary i (2007) (7)
Relative Efficacy of Spironolactone, Eplerenone, and cAnRenone in patients with Chronic Heart failure (RESEARCH): a systematic review and network meta-analysis of randomized controlled trials (2019) (7)
Antiplatelet ‘resistance’ and ‘non‐responders’: what do these terms really mean? (2009) (7)
The use of a tissue expander in clubfoot surgery (1991) (7)
Cardiac Magnetic Resonance Evaluation of the Extent of Myocardial Injury in Patients with Inferior ST Elevation Myocardial Infarction and Concomitant ST Depression in Leads V1–V3: Analysis from the MITOCARE Study (2018) (7)
Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry (2022) (7)
Cauda Equina Syndrome in a 36 Week Gravida Patient. (2015) (7)
EFFICACY AND SAFETY OF APIXABAN COMPARED WITH WARFARIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION IN PATIENTS TAKING CONCOMITANT ASPIRIN (2012) (7)
Changes in diagnosing non-ST-segment elevation myocardial infarction after the introduction of a new high-sensitivity cardiac troponin T assay: a single-centre experience. (2012) (7)
Cost-effectiveness of antiplatelet drugs after percutaneous coronary intervention (2015) (7)
How does the TRS 2°P score relate to real-world patients? (2018) (7)
The course of D-dimer, high-sensitivity C-reactive protein and pro-B-type natriuretic peptide in patients with non-ST-elevation myocardial infarction. (2011) (7)
Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1. (2019) (6)
[Hyperkalemia and impaired renal function in patients taking spironolactone for congestive heart failure. A retrospective analysis of 125 consecutive cases]. (2004) (6)
Impact of climate and air pollution on acute coronary syndromes: an update from the European Society of Cardiology Congress 2017 (2018) (6)
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research (2022) (6)
Increases in Circulating Cardiac Troponin Are Not Always Associated with Myocardial Cell Death. (2018) (6)
Platelets and Thrombolysis: Cooperation or Contrariety? (2001) (6)
Viscosupplementation with algae-polysaccharides in the treatment of arthritis (2006) (6)
Matrix metalloproteinases and the activity of their tissue inhibitors in patients with ST-elevation myocardial infarction treated with primary angioplasty. (2013) (6)
Mechanisms of action and clinical use of specific reversal agents for non-vitamin K antagonist oral anticoagulants (2018) (6)
Why Not Dipyridamole: a Review of Current Guidelines and Re-evaluation of Utility in the Modern Era (2021) (6)
Obstructive sleep apnea: no independent association to troponins (2014) (6)
A canine model of acute coronary artery thrombosis for the evaluation of reperfusion strategies. (1994) (6)
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research (2022) (6)
Spironolactone Treatment and Effect on Survival in Chronic Heart Failure Patients with Reduced Renal Function: A Propensity-Matched Study (2017) (6)
[Trends and characteristics of diabetes-related lower limb amputations in the Negev, 1996-1999]. (2006) (6)
[Combined treatment for adhesive capsulitis of the shoulder]. (1997) (6)
Platelet activation as a universal trigger in the pathogenesis of acute coronary events after cocaine abuse. (2001) (5)
Electrocardiographic scores of severity and acuteness of myocardial ischemia predict myocardial salvage in patients with anterior ST-segment elevation myocardial infarction. (2017) (5)
Regional LV deformation in healthy individuals during isovolumetric contraction and ejection phases assessed by 2D speckle tracking echocardiography (2012) (5)
Internal Fixation with Biodegradable Plate and Screws in Dogs (1994) (5)
Failure of Platelet Parameters and Biomarkers to Correlate Platelet Function to Severity and Etiology of Heart Failure in Patients Enrolled in the EPCOT Trial (2002) (5)
Non-vitamin K oral anticoagulants in 'valvular' atrial fibrillation: a call for action. (2016) (5)
Gender but not diabetes, hypertension or smoking affects infarct evolution in ST-elevation myocardial infarction patients – data from the CHILL-MI, MITOCARE and SOCCER trials (2019) (5)
Assessment of Right Ventricular Afterload in COPD (2016) (5)
Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial. (2020) (5)
New method of limb deformities correction in children. (1992) (5)
[Atrial fibrillation and stroke]. (2013) (5)
Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage (2020) (5)
Medical and Ventilatory Treatment of Acute Heart Failure: New Insights (2006) (5)
Cell Adhesion Molecules in Cardiovascular Pathology – A Glance into the Future? (2001) (5)
Prevalence of genetically verified familial hypercholesterolemia among young (<45 years) Norwegian patients hospitalized with acute myocardial infarction. (2020) (5)
Excision of the Posterior Tibial Tendon During Clubfoot Release (1993) (5)
All-Cause Mortality and Cardiovascular Outcomes With Non-Vitamin K Oral Anticoagulants Versus Warfarin in Patients With Heart Failure in the Food and Drug Administration Adverse Event Reporting System. (2019) (5)
Troponin I degradation in serum of patients with acute ischemic stroke (2011) (5)
Pre-hospital One-Hour Troponin in a Low-Prevalence Population of Acute Coronary Syndrome: OUT-ACS study (2020) (5)
Minimizing treatment complexity of combat-related soft tissue injuries using a dedicated tension relief system and negative pressure therapy augmented by high-dose in situ antibiotic therapy and oxygen delivery: a retrospective study (2021) (5)
Fatal sepsis and systemic inflammatory response syndrome after off-label prasugrel: a case report. (2014) (5)
Correlation of anteroseptal ST elevation with myocardial infarction territories through cardiovascular magnetic resonance imaging. (2018) (5)
Myocardium at risk assessed by electrocardiographic scores and cardiovascular magnetic resonance - a MITOCARE substudy. (2017) (5)
Diagnostic Accuracy and Usability of the ECG247 Smart Heart Sensor Compared to Conventional Holter Technology (2021) (5)
Effect of Coronary Thrombolysis on the Plasma Concentration of Osteonectin (SPARC, BM40) in Patients with Acute Myocardial Infarction (2000) (5)
Aggrenox® (Extended-Release Dipyridamole and Low-Dose Aspirin in Combination): Protecting Platelets from Excessive Activation in Patients with Vascular Events (2002) (5)
Pelvic osteotomies in children. (1992) (4)
The Use of Tissue Expanders in Clubfoot Surgery (1994) (4)
Myeloid-related protein-8/14 and C-reactive protein in individuals evaluated for obstructive sleep apnea. (2014) (4)
Between observer variation is not eliminated by standardised analysis of dobutamine–atropine stress echocardiography (2002) (4)
ESC Guidelines on the management of acute myocardial infarction with persistent ST-segment elevation (2012) (4)
On-label reduced doses of non-vitamin K anticoagulants prove safe and efficient; yet how to ensure the correct dose for the right patient? (2019) (4)
Statins attenuate but do not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failure. (2017) (4)
Do We Really Need Aspirin Loading for STEMI? (2022) (4)
Relation of cardiac troponin I and microvascular obstruction following ST-elevation myocardial infarction (2011) (4)
[European practice guidelines on prevention of cardiovascular diseases: executive summary]. (2008) (4)
Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status an analysis from the high-risk myocardial infarction database initiative. (2017) (4)
Prasugrel: the real-life perspective. (2013) (4)
Discitis in children. (1992) (4)
Administration of the Mitochondrial Permeability Transition Pore Inhibitor, TRO40303, prior to Primary Percutaneous Coronary Intervention, Does Not Affect the Levels of Pro-Inflammatory Cytokines or Acute-Phase Proteins (2017) (4)
Troponin I measurement in the diagnosis of myocardial injury during pregnancy and delivery: two cases. (2000) (4)
Comparison of a single high-sensitivity cardiac troponin T measurement with the HEART score for rapid rule-out of acute myocardial infarction in a primary care emergency setting: a cohort study (2021) (4)
Cardioversion Safety – Are We Doing Enough? (2020) (4)
[Emergency room consultation policy prevents surgery delay in elderly patients with hip fractures]. (2005) (4)
PROGNOSTIC VALUE OF MICROVASCULAR OBSTRUCTION AND INFARCT SIZE MEASURED BY CARDIAC MAGNETIC RESONANCE IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: A META-ANALYSIS OF INDIVIDUAL PATIENT DATA (2013) (4)
Atrial fibrillation in cryptogenic stroke and TIA patients in The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Main results (2022) (3)
Pharmacogenomics in cardiovascular clinical trials (2004) (3)
The Diagnostic Value of the Vacuum Phenomenon during Hip Arthroscopy (2011) (3)
Challenging Anticoagulation in Advanced Renal Failure. (2019) (3)
[The diabetic foot]. (1999) (3)
In Current Clinical Practice, after Percutaneous Coronary Intervention for Acute Myocardial Infarction, Are β-Blockers Prescribed for Heart Failure or as Secondary Prevention? A Pilot Study (2018) (3)
Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction. (2019) (3)
Pathophysiology and clinical manifestation (2012) (3)
End of story? Studies on prevention of reperfusion injury encounter perpetual defeats. (2015) (3)
Inferior ST-Elevation Myocardial Infarction Presenting When Urgent Primary Percutaneous Coronary Intervention Is Unavailable: Should We Adhere to Current Guidelines? (2020) (3)
New anticoagulants in combination with antiplatelet agents. (2016) (3)
No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumab (2022) (3)
Appropriateness of anteroseptal myocardial infarction nomenclature evaluated by late gadolinium enhancement cardiovascular magnetic resonance imaging. (2017) (3)
A window into your heart: taking cardiac troponin to the next level. (2010) (3)
[Congestive heart failure--etiology and diagnostic procedures]. (2007) (3)
Asymptomatic Myocardial Infarction prior to Ischemic Stroke? (2007) (3)
Bilateral Dislocation Of The Hip During Convulsions: A Case Report (1997) (3)
Neck metaphyseal angle guidance in proximal femoral varus osteotomy. (1990) (3)
Editorial: Sudden cardiac death – the challenge to cardiology (2010) (3)
Multiple dorsal dislocations of the metacarpophalangeal joints: a case report and review of the literature. (1998) (3)
Pavlik Harness Pathology (1991) (3)
One-year outcomes in atrial fibrillation patients with versus without a previous stroke or transient ischaemic attack: findings from the international prospective GARFIELD registry (2013) (2)
Dyspnoea after AZD 6140: blaming the messenger (2007) (2)
Outcomes after rhythm versus rate control in patients with atrial fibrillation: the international prospective GARFIELD registry (2013) (2)
Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data (2021) (2)
High Sensitivity Troponin I for Risk Assessment in Patients with Atrial Fibrillation: Insights from the ARISTOTLE Trial (2013) (2)
Profound ECG abnormalities during emergency cesarean section in a patient with pre-eclampsia. (1999) (2)
Cryptogenic stroke and TIA: Suggested diagnostic approach while waiting for evaluation and treatment guidelines (2022) (2)
Antidotbehandling ved bruk av direktevirkende antikoagulasjonsmidler (2018) (2)
APIXABAN COMPARED WITH WARFARIN IN PATIENTS WITH DIABETES AND NONVALVULAR ATRIAL FIBRILLATION IN THE ARISTOTLE TRIAL (2014) (2)
Worst lead ST deviation and resolution of ST elevation at one hour for prediction of myocardial salvage, infarct size, and microvascular obstruction in patients with ST‐elevation myocardial infarction treated with primary percutaneous coronary intervention (2020) (2)
Does Ivabradine Decrease Cardiovascular Deaths in Heart Failure Patients? (2020) (2)
Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE (2023) (2)
[Establishment of a nurse-led heart failure clinic. Design and baseline data from the first two years]. (2003) (2)
Correlation of ST changes in leads V4–V6 to area of ischemia by CMR in inferior STEMI (2018) (2)
Selective Serotonin Reuptake Inhibitors: Future Treatment of Vascular Disease? (2001) (2)
Mean wall thickness improves characterization and prognosis in left ventricular hypertrophy (2019) (2)
Effect of oral b -blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis (2018) (2)
The Role of ECG in the Diagnosis and Risk Stratification of Acute Coronary Syndromes: an Old but Indispensable Tool (2022) (2)
[Vacuum phenomenon in the hip joint: diagnostic value]. (1998) (2)
Doppler indices of diastolic transmitral flow velocity are invalid indicators of myocardial ischaemia during high-dose dobutamine infusion in anaesthetized patients (2002) (2)
MVnet: automated time-resolved tracking of the mitral valve plane in CMR long-axis cine images with residual neural networks: a multi-center, multi-vendor study (2021) (2)
A Comprehensive Review of the Pleiotropic Effects of Ticagrelor (2022) (2)
Angiotensin receptor neprilysin inhibition for the treatment of hypertension: the neglected child in cardiovascular pharmacotherapy. (2019) (2)
Rehabilitation of the hand after an explosion injury. (1991) (2)
Do we need new lipid-lowering agents in the era of PCSK9 inhibitors? Recent advances. (2022) (2)
Aktywność metaloproteinaz macierzy i ich inhibitorów u pacjentów z zawałem serca z uniesieniem odcinka ST leczonych pierwotną angioplastyką wieńcową (2013) (2)
Interpreting clinical trials: the ‘Beautiful’ case (2009) (2)
LCZ696, an angiotensin receptor neprilysin inhibitor, attenuates renal fibrosis after myocardial infarction and reduces angiotensin-II-mediated renal cellular collagen synthesis (2015) (2)
Technique Tips: Triple Arthrodesis (1990) (2)
The diagnostic value of exercise echocardiography in ischemic heart disease in relation to quantitative coronary arteriography (1995) (2)
Cardiovascular phenotype of long‐term anabolic‐androgenic steroid abusers compared with strength‐trained athletes (2022) (2)
Questionable levels of evidence in new atrial fibrillation guidelines (2013) (2)
In ST-Elevation myocardial infarction patients receiving primary percutaneous coronary intervention, admission cardiac troponin T and peak cardiac troponin T values differ in their prognostic properties. (2009) (2)
The evolution of myocardium at risk by T2-STIR MR imaging the first week after acute myocardial ischemia (2016) (1)
ILIZAROV TECHNIQUE IN TREATMENT OF CONGENITAL HAND ANOMALIES. TWO CASE REPORTS (1992) (1)
Underlying causes of cryptogenic stroke and TIA in the nordic atrial fibrillation and stroke (NOR-FIB) study – the importance of comprehensive clinical evaluation (2023) (1)
Cardiovascular risk associated with long-term anabolic-androgenic steroid abuse: an observational study from Norway (2021) (1)
[How to diagnose a heart attack in 2012?]. (2012) (1)
Rheumatic mitral valve stenosis mimicking advanced lung cancer (2007) (1)
CT-guided excision of osteoid osteoma. (1993) (1)
The Heart Valve Society. 2nd Annual Meeting, March 17-19, 2016, New York City, N.Y., USA: Abstracts (2016) (1)
[Hip arthroscopy--indications, surgical technique and implementation]. (2004) (1)
Design of clinical cardioprotection trials using CMR: impact of myocardial salvage index and a narrow inclusion window on sample size (2015) (1)
Author’s response to: letter to the editor (2018) (1)
‘Patient choice’ concept in AF ESC Guidelines: is the clinician giving up? Reply (2013) (1)
Abstract 1655: Diuretic Doses and Mortality in 3632 Patients With Stable Chronic Heart Failure (2009) (1)
Vitamin D supplementation improves endothelial function in type 2 diabetes – A randomized controlled trial (2013) (1)
Left ventricular mass and global wall thickness -- prognostic utility and characterization of left ventricular hypertrophy (2022) (1)
P4392Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status (2017) (1)
Angiotensin Receptor Neprilysin Inhibition (ARNi) Attenuates Adverse Cardiac Remodelling In Vitro and In Vivo (2013) (1)
Telmisartan and Stroke Reduction in the ONTARGET Trial: Benefit beyond Blood Pressure Lowering? (2008) (1)
European guidelines regarding the prevention of cardiovascular disease in clinical practice: a shorter version (2008) (1)
In memoriam Henry Krum, 1958-2015 (2016) (1)
Optimal time-point of ST-segment assessment for risk-stratification following primary percutaneous coronary intervention. (2010) (1)
Performance of contrast enhanced SSFP and T2-weighted imaging for determining myocardium at risk in a multi-vendor, multi-center setting- data from the MITOCARE and CHILL-MI trials (2015) (1)
Type 2 Diabetes and Heart Failure - More Scrutiny Wanted! (2017) (1)
Leisure activities of old people in the kibbutz. (1981) (1)
Triple arthrodesis. (1990) (1)
Growing pains (2009) (1)
Cost-effectiveness of a rule-out algorithm of acute myocardial infarction in low-risk patients: emergency primary care versus hospital setting (2022) (1)
Behandling av kronisk hjertesvikt (2007) (1)
MINIMAL-INCISION TOTAL HIP ARTHROPLASTY (2005) (1)
Kronisk hjertesvikt – etiologi og diagnostikk (2007) (1)
[Medical and ventilatory treatment of acute heart failure]. (2006) (1)
TUMOR NECROSIS FACTOR-ALPHA ANTAGONISTS IMPROVE AORTIC STIFFNESS IN PATIENTS WITH INFLAMMATORY ARTHROPATHIES: A ONE YEAR CONTROLLED STUDY: PP.10.412 (2010) (1)
Intra-operative arthrography in open reduction of congenital hip dislocation. (1990) (1)
Use of Non-vitamin K Antagonist Oral Anticoagulants for Stroke Prevention across the Stroke Spectrum: Progress and Prospects (2021) (1)
Universitet Integrating new approaches to atrial fibrillation management the 6 th AFNET / EHRA Consensus Conference (2018) (1)
Automatic segmentation of myocardium at risk from contrast enhanced SSFP CMR: validation against expert readers and SPECT (2016) (1)
Hip dislocation caused by infantile myofibromatosis. (1995) (1)
Peripheral arterial disease and limb salvage: a new arena for the cardiologist. (2018) (1)
Cholesterol and peripheral vascular disease: A neglected topic? (2007) (1)
[Necrotizing soft tissue infection]. (1998) (1)
The diagnostic value of Doppler echocardiographic indexes of diastolic filling for detecting demand ischemia in anesthetized patients (2000) (1)
Is RBBB the new LBBB? Are we going to repeat the same mistakes? (2021) (1)
Characteristics, treatment patterns, and residual cardiovascular risk of patients with a first acute myocardial infarction: A nationwide population‐based cohort study in Norway (2021) (1)
Infarct quantification with cardiovascular magnetic resonance using "standard deviation from remote" is unreliable: validation in multi-centre multi-vendor data (2022) (1)
The Times They Are A-Changin´: Antithrombotic strategies in patients with acute coronary syndrome undergoing coronary stenting who have concomitant atrial fibrillation. (2021) (1)
Erratum to “Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency” [Eur J Heart Fail 2016;18:482‐489] (2016) (1)
Levosimendan: perpetuum mobile? (2007) (1)
Effects of FX06 In Vitro on Platelet, Coagulation, and Fibrinolytic Biomarkers in Volunteers and Patients With Documented Coronary Artery Disease (2014) (1)
The association of smoking to cardiovascular death differs according to age and sex following myocardial infarction complicated by heart failure or left ventricular dysfunction (2020) (1)
Performance of the Novel Observation Group Criteria of the European Society of Cardiology (ESC) 0/1‐Hour Algorithm in a Low‐Risk Population (2022) (1)
Hyperkalemia and impaired renal function during treatment with spironolactone in patients with congestive heart failure: Figures from a real world scenario (2003) (1)
Modulating the Intensity of Oral Anticoagulation Therapy with Direct Oral Anticoagulants: Feasible or Not? (2021) (1)
Ivabradine for heart failure: regulatory differences in Europe and United States. (2019) (0)
EARLY PREDICTORS OF CARDIOVASCULAR DISEASE (CVD) RISK: A 15-YEAR FOLLOW-UP STUDY OF 108 PATIENTS WITH RHEUMATOID ARTHRITIS (RA): PP.10.383 (2010) (0)
Randomized, open-label, crossover trial comparing the pharmacokinetic profile of a novel oral aspirin solution and a chewed aspirin tablet (2022) (0)
Front & Back Matter (2014) (0)
Abstract 10682: Is Acute Heart Failure Admission Linked to a Change in Temperature? Insights from ASCEND-HF (2011) (0)
Antiplatelet therapy in ACS and A-Fib (2012) (0)
OPEN REDUCTION AND INTERNAL FIXATION WITH REMOVABLE KIRSCHNER WIRES AND ABSORBABLE SUTURES OF OLECRANON FRACTURES IN CHILDREN (2005) (0)
HIP ARTHROSCOPY – THE PERIPHERAL COMPARTMENT (2008) (0)
Positive Trends in FIRE Hint at Protection from Reperfusion Injury (2008) (0)
[Anemia, abnormal ECG, shock]. (1990) (0)
Pathophysiology , diagnosis and management of no reflow (2020) (0)
USE OF ARTHROGRAPHY FOR ASSESSMENT OF LATERAL CONDYLE FRACTURES IN CHILDREN (2006) (0)
Improvement in Aortic Stiffness After one Year of Anti-Tumor Necrosis Factor-α Therapy in Patients with Inflammatory Arthropathies is Associated with Reduction in Calprotectin (A Proinflammatory S100 Protein) (2009) (0)
Electrocardiographic ST-T changes in patients with acute ischemic stroke are cardiac in origin (2007) (0)
[Can myocardial damage following heart infarct be reversible?]. (1997) (0)
«Falskt positive troponinverdier» finnes ikke (2017) (0)
Apiksaban – refusjon på blåresept for ikke-valvulær atrieflimmer (2013) (0)
New automatic algorithm for segmentation of myocardial scar in both inversion recovery and phase sensitive inversion recovery late gadolinium enhancement: validation against TTC and in multi-center, multi-vendor patient data (2016) (0)
Reactivity of coronary arteries in relation to serum magnesium levels in patients with ischaemic heart disease--a quantitative coronary angiographic study. (1995) (0)
Clopidogrel in Atrial Fibrillation: Is There Any Justification Now in the Era of New Anticoagulants? (2012) (0)
[Arthroscopic surgery of the knee with CO2 laser surgery of the knee]. (1996) (0)
Outcomes at 1 year in atrial fibrillation patients with versus without an acute coronary syndrome: insights from the prospective GARFIELD Registry (2013) (0)
Levels of NT-proBNP are associated with arterial stiffness in patients with Rheumatoid arthritis (2008) (0)
Abstract 3889: Antecedent Aspirin Dose and Platelet Inhibition with Clopidogrel in Patients After Coronary Stenting and Ischemic Stroke: Analysis of 711 cases of Dual Antiplatelet Therapy (2006) (0)
Re: Antikoagulasjon og akronymer – NOAK eller DOAK? (2017) (0)
Thanks to Reviewers2017 (2017) (0)
Efficacy and safety of dronedarone vs placebo in patients with atrial fibrillation or atrial flutter across a spectrum of renal function: post hoc analyses of the EURIDIS-ADONIS trials (2020) (0)
385 Value of left ventricular filling parameters to predict mortality in a sample of subjects with preserved systolic function from the general population (2006) (0)
Abstract 2396: Consistent Platelet Inhibition After Chronic Maintenance Dose Clopidogrel Therapy Among 359 Compliant Outpatients with Documented Ischemic Stroke and Coronary Artery Disease (2006) (0)
Valves in the Heart of the Big Apple V: Evaluation and Management of Valvular Heart Diseases 2007.Third Annual Scientific Session: Heart Valve Society of America, New York City, N.Y., April 12–14, 2007 (2007) (0)
Efficacy and Safety of Apixaban in Patients With Atrial Fibrillation According to Sex : Results From the ARISTOTLE Trial (2013) (0)
Iconographies supplémentaires de l'article : Usefulness of Natriuretic Peptide Testing for Long-Term Risk Assessment Following Acute Ischemic Stroke (2011) (0)
RESPONSE: Climate Change and Health: Challenges, Opportunities, and the Need for Action. (2023) (0)
Subject Index Vol. 94, 2000 (2001) (0)
Detection of atrial fibrillation in patients with cryptogenic stroke: The Nordic Atrial Fibrillation and Stroke (NOR-FIB) study - topline results (2022) (0)
O-C.W. Rutherford og medarbeidere svarer (2018) (0)
Subject Index Vol. 1, 2001 (2001) (0)
THE USE OF STRUCTURAL ALLOGRAFT IN REVISION TOTAL KNEE ARTHROPLASTY IN SOROKA MEDICAL CENTER (2006) (0)
Abstract 2785: Electrocardiographic ST-T Changes In Patients With Acute Ischemic Stroke Are Cardiac In Origin (2007) (0)
REMISSION IS THE MISSION: A POPULATION CONTROLLED STUDY OF CVD RISK MARKERS IN RHEUMATOID ARTHRITIS (RA): 1B.04 (2010) (0)
FCP welcomes Cardiovascular Pharmacology and Drug Therapy (2007) (0)
[Fracture of the supracondylar process of the humerus associated with Monteggia fracture]. (2002) (0)
610 ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE (ALCAM) AND PROGNOSIS IN ACUTE ISCHEMIC STROKE (2011) (0)
Increased crp early in the ra disease course predicts an increased risk of cardiovascular disease and arterial stiffness: 15-year follow-up of the euridiss cohort (2009) (0)
Prediction of microvascular obstruction following primary percutaneous coronary intervention (2011) (0)
Consistent Platelet Inhibition During Long-Term Maintenance Clopidogrel Therapy Among Three Hundred Fifty-Nine Compliant Outpatients with Documented Vascular Disease (2007) (0)
CONGENITAL INSENSITIVITY TO PAIN. THE SPECTRUM OF MUSCULO SKELETAL DISORDERS (2008) (0)
THE PRESCRIBING OF ANTIPLATELET THERAPY ONLY IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION: RESULTS FROM THE GARFIELD-AF REGISTRY (2017) (0)
peak cTnT values originating from pre- PCI sampling. To confuse matters further, in the dis- (2009) (0)
The efficacy and safety of apixaban versus warfarin are preserved in patients with atrial fibrillation and extreme body weight: Insights from the ARISTOTLE Study (2018) (0)
ASSOCIATION OF PLATELET RESPONSIVENESS WITH CLOPIDOGREL METABOLISM: ROLE OF COMPLIANCE IN THE ASSESSMENT OF “RESISTANCE” (2010) (0)
P2.06: LEVELS OF NT-PROBNP ARE ASSOCIATED WITH ARTERIAL STIFFNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS (0)
Administration Are Associated With Improvement in Myocardial Contractile Performance in Dilated Cardiomyopathy Patients (2013) (0)
Contents Vol. 1, 2001 (2001) (0)
The effects of exercise training in patients with persistent dyspnoea after pulmonary embolism: a randomized controlled trial (2023) (0)
Gir ACE-hemmere og angiotensinreseptorantagonister økt risiko for alvorlig covid-19? (2020) (0)
P6392Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction (2018) (0)
[The painful shoulder--differential diagnosis, assessment and treatment]. (1998) (0)
The extent of myocardium at risk for LAD, RCA and LCx using contrast enhanced SSFP and T2-weighted imaging (2015) (0)
Digital secondary prevention follow-up after percutaneous coronary intervention (PCI) at home: what are the users perspectives? (2021) (0)
USE OF PROXIMAL FEMORAL ALLOGRAFT FOR ACETABULAR BONE DEFICIENCY IN REVISION HIP ARTHROPLASTY (2002) (0)
Fully digital self-screening for atrial fibrillation with patch electrocardiogram. (2023) (0)
Abstract 17219: Vitamin D Supplementation Improves Endothelial Function In Type 2 Diabetes - A Randomized Controlled Trial (2013) (0)
REDUCTION IN TOTAL CARDIOVASCULAR EVENTS WITH THE PCSK9 INHIBITOR EVOLOCUMAB IN PATIENTS WITH CARDIOVASCULAR DISEASE IN THE COMBINED FOURIER AND FOURIER OPEN-LABEL EXTENSION (OLE) STUDIES (2023) (0)
PROGNOSTIC SIGNIFICANCE OF MICROVASCULAR OBSTRUCTION AND INFARCT SIZE MEASURED BY CARDIOVASCULAR MAGNETIC RESONANCE FOR THE ASSESSMENT OF LEFT VENTRICULAR REMODELING IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: INSIGHT FROM A POOLED ANALYSIS OF INDIVIDUAL PATIENT DATA (2014) (0)
Examination of effects of Tnf-alpha antagonists on arterial stiffness in patients with rheumatoid arthritis and related arthropathies: a controlled study (2008) (0)
Abstract 717: Spatial And Temporal Nonuniformity Of The Normal Left Ventricle During Isovolumic Contraction And Ejection By 2D Speckle Tracking Imaging (2008) (0)
Welcome Address – from the Editors (2000) (0)
P1520Maternal cardiovascular status after pregnancies complicated by preeclampsia or diabetes (2017) (0)
[Antidote treatment during use of direct anticoagulants]. (2018) (0)
Combining High Sensitivity Troponin I and T Measurements Improves Prediction of Long-Term Clinical Outcomes in Patients With Atrial Fibrillation - An Aristotle Substudy (2013) (0)
Cardiovascular pharmacotherapy. (2016) (0)
“I’ve kept going” – a multisite repeated cross-sectional study of healthcare workers’ pride in personal performance during the COVID-19 pandemic (2023) (0)
Abstract 4964: Tnf-{alpha}Antagonists Improve Arterial Stiffness in Patients With Inflammatory Arthropathies: Results From a One Year Controlled Study (2009) (0)
SURGICAL MANAGEMENT OF SEVERELY INVOLVED ADOLSCENTS AND YOUNG ADULTS WITH CEREBRAL PALSY (2006) (0)
3.2% OF YOUNG SUBJECTS UNDER 45 YEARS WITH ACUTE MYOCARDIAL INFARCTION HAVE GENETICALLY VERIFIED FAMILIAL HYPERCHOLESTEROLEMIA (2018) (0)
Subject Index Vol. 107, 2007 (2006) (0)
Biomarkers predictive of atrial fibrillation in patients with cryptogenic stroke. Insights from the Nordic Atrial Fibrillation and Stroke (NOR‐FIB) study (2023) (0)
CORONARY ARTERY DISEASE AND CARDIOVASCULAR OUTCOMES IN HEART FAILURE: INSIGHTS FROM THE VERICIGUAT GLOBAL STUDY IN SUBJECTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION (VICTORIA) TRIAL (2021) (0)
Nordic-Baltic Congress of Cardiology: 24th Congress, Oslo, June 2013: Abstracts and Program (2013) (0)
Abstract 2237: Left Ventricular Systolic Torsion by 2-D Speckle Tracking Imaging is Load Dependent (2006) (0)
Icons in Cardiology (2021) (0)
Author’s reply (2010) (0)
Coral from Australian reef used to replace bone. (1999) (0)
Hotline sessions of the 30th European Congress of Cardiology (2009) (0)
Achieving the unachievable: How to optimize lipid-lowering therapy in survivors of acute myocardial infarction. (2023) (0)
360Role of cardioversion in the management of non-valvular atrial fibrillation: insights from the GARFIELD-AF registry (2018) (0)
Impact of Bleeding on Myocardial Infarction, Stroke and Death During 12-months Dual Antiplatelet Therapy After Acute Coronary Syndrome. (2022) (0)
A single high-sensitivity cardiac troponin T compared to the HEART score for a rapid rule-out of acute myocardial infarction at a prehospital emergency clinic (2020) (0)
Time course of death after acute coronary syndrome treated with dual antiplatelet therapy for one year. (2023) (0)
[Health and health care in Norway]. (2007) (0)
Contents Vol. 107, 2007 (2006) (0)
P4601Differences in two-year outcomes according to type of atrial fibrillation: results from the GARFIELD-AF registry (2017) (0)
614 FATTY ACID BINDING PROTEIN 4 AS A BIOMARKER OF CAROTID ATHEROSCLEROSIS AND OUTCOME IN PATIENTS WITH ACUTE ISCHEMIC STROKE (2011) (0)
TRO40303 Lacks Protective Effect in PCI: Results from MITOCARE (2014) (0)
The L-arginine/asymmetric dimethylarginine (ADMA) ratio is improved during anti-Tumor Necrosis Factor–α therapy in patients with inflammatory arthropathies: Association with aortic stiffness (2011) (0)
The Perils of Data Sharing, Meta-analyses, and Estimating Rosiglitazone Cardiovascular Risk. (2020) (0)
296 LV systolic torsion is dependent while diastolic untwisting is independent of alterations in preload measured by 2-D speckle tracking imaging (2006) (0)
Effect of Aliskiren and Valsartan Combination Versus Aliskiren Monotherapy on Hemostatic Biomarkers in Hypertensive Diabetics: Aliskiren and Valsartan Impact in Diabetics Pilot Trial (2014) (0)
Patients with atrial fibrillation and history of falls are at high risk for bleeding but have less bleeding with apixaban than warfarin : results from the ARISTOTLE trial (2016) (0)
Acknowledgement to Reviewers 2015 (2015) (0)
Editors’ Introductory Note (2002) (0)
one-renin ratio are independent predictors of PWV in severe form of essential hypertension. PP.10.411 NEBIVOLOL BUT NOT METOPROLOL DECREASES CENTRAL BLOOD PRESSURE AND LEFT VENTRICULAR WALL THICKNESS IN PATIENTS WITH ESSENTIAL HYPERTENSION (2010) (0)
The authors' reply: (2011) (0)
Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction: a propensity score-matched cohort study (2013) (0)
AN “ALMOST” PERCUTANEOUS TRIPLE PELVIC OSTEOTOMY TO OBTAIN FEMORAL HEAD COVERAGE IN CHILDREN 6–14 YEARS OF AGE (2002) (0)
IN CLUB-FOOT SURGERY A CASE REPORT AND REVIEW (1990) (0)
ST CHANGES IN ELECTROCARDIOGRAPHIC LEADS V4-V6 IN PATIENTS WITH INFERIOR MYOCARDIAL INFARCTION PREDICT EXTENT AND DISTRIBUTION OF ISCHEMIC INJURY AS EVALUATED BY CARDIAC MAGNETIC RESONANCE: ANALYSIS FROM THE MITOCARE STUDY (2018) (0)
Editors’ Introductory Note (2001) (0)
Early inflammation can predict arterial stiffness: a 15-year longitudinal study of 102 patients with Rheumatoid Arthtritis (2008) (0)
Abstract 15603: Does Repeat Measurement of High Sensitivity Troponin I Improve Prediction of Cardiovascular Events in Atrial Fibrillation? (2014) (0)
Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation – results from the GARFIELD-AF registry (2021) (0)
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research (2022) (0)
Predicting clinical outcomes after clopidogrel use: easier to postulate than to prove and implement. (2019) (0)
Subject Index Vol. 4, 2004 (2004) (0)
Postpoliomyelitis syndrome problems of knee function: a review. (1993) (0)
Intensification of antithrombotic therapy for chronic atherosclerosis. (2020) (0)
GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide (2022) (0)
Does isolated diastolic dysfunction explain dyspnea in a population with preserved left ventricular systolic function and no signs of lung disease (2003) (0)
Calcium Intake is Independently Associated with Increased Augmentation Index: Results from a Cross-Sectional Follow-Up Study of Two Rheumatoid Arthritis Cohorts (2009) (0)
The ArthritisInflammation: A 15-year Followup Study of 108 Patients with Rheumatoid Early Prediction of Increased Arterial Stiffness in Patients with Chronic (2011) (0)
Terror-Related Trauma (2015) (0)
4804Anti-EDA antibody injection 3 days after myocardial infarction prevents heart failure development and aneurysm formation in mice and pigs (2017) (0)
MINIMAL INVASIVE OPEN REDUCTION AND INTERNAL FIXATION OF PROXIMAL HUMERAL FRACTURES WITH A LOCKING COMPRESSION PLATE. SHORT TERM CLINICAL RESULTS AND COMPLICATIONS (2006) (0)
Magnesium and myocardial infarction (1994) (0)
[Myocardial reperfusion: salvation or danger for the heart muscle? Stunning, hibernation and preconditioning: the states of endogenous cardiac protection against ischemia]. (1997) (0)
SPORT INJURIES IN THE LUMBAR SPINE OF ADOLESCENT ATHLETES (2002) (0)
3298Prehospital assessment of the one-hour rule-in/rule-out algorithm using a high-sensitivity cardiac troponin t assay in a low-prevalence population for acute coronary syndrome (OUT-ACS) (2019) (0)
Prevalence Of Genetically Verified Familial Hypercholesterolemia Among Young Norwegian Patients (45 Years) Hospitalized With Acute Myocardial Infarction (2019) (0)
Tibialis posterior interpositional graft in club foot surgery (1992) (0)
The National Cardiac Societies of the European Society of Cardiology. (2015) (0)
Infusion of TRO40303 in patients with ST-elevation myocardial infarction prior to primary percutaneous coronary intervention did not alter levels of inflammatory biomarkers in the MITOCARE study (2016) (0)
Implementing screening for myocardial injury in non-cardiac surgery: perspectives of an ad-hoc interdisciplinary expert group. (2022) (0)
P1814Deaths and vascular outcomes with non-vitamin K oral anticoagulants versus warfarin in patients with heart failure in the food and drug administration adverse event reporting system (2018) (0)
P5346Worst lead residual ST-deviation 60 minutes after primary PCI for STEMI is associated with infarct size and myocardial salvage on cardiac magnetic resonance imaging (2017) (0)
IMPROVEMENT IN AORTIC STIFFNESS DURING ANTI-TUMOR NECROSIS FACTOR-ALPHA THERAPY IN PATIENTS WITH INFLAMMATORY ARTHROPATHIES IS ASSOCIATED WITH REDUCTION IN CALPROTECTIN: 3A.05 (2010) (0)
Introduction. Antiplatelet therapy in ACS and A-Fib. (2012) (0)
Contents Vol. 131, 2015 (2015) (0)
[Fractures of the calcaneus--new trends in management]. (1997) (0)
EDITORIAL (2007) (0)
Abstract 2642: Prevalence and Importance of Cardiac Arrhythmias after Acute Ischemic Stroke (2008) (0)
Left ventricular global wall thickness is easily calculated, detects and characterizes hypertrophy, and has prognostic utility (2019) (0)
Do ACE inhibitors and angiotensin receptor antagonists increase the risk of severe COVID-19? (2020) (0)
Contents Vol. 4, 2004 (2004) (0)
Results of Complete Repeat Son Tissue Clubfoot Release Combined with Calcaneocuboid Fusion in the 5–8 Year Age Group (1997) (0)
The debated issue of direct oral anticoagulants correct dosing: When even the reviewer is confused. (2021) (0)
Pharmacotherapy in Prevention and Rehabilitation (2007) (0)
velocities: influences of relaxation and preload Determinants of diastolic myocardial tissue Doppler (2015) (0)
Physeal separation of the distal humerus, a rare consequence of trauma at birth. Case report (2006) (0)
P5272Concomitant heart failure (HF) and type 2 diabetes (T2D) - a deadly duo (2017) (0)
Abstract 13368: Angiotensin-Receptor Neprilysin-Inhibitor Reduces Adverse Cardiac Remodeling after Experimental Myocardial Infarction by Direct Effect on Cardiac Hypertrophy and Fibrosis (2013) (0)
[Pelvic lytic lesion, and the need to suspect osteoporosis-related fractures]. (1998) (0)
'Patient choice' concept in AF ESC Guidelines: is the clinician giving up? Reply. (2013) (0)
Biomarkers and Exercise Training: A Possible Missing Link between Physical Activity and Mortality Benefit in Patients with Heart Failure (2001) (0)
Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease: 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), Association for Acute CardioVascular Care (ACVC) and European Association of Pr (2023) (0)
A simplified left ventricular end-diastolic mean wall thickness-to-volume ratio estimated from left ventricular mass and end-diastolic volume distinguishes physiological from pathological hypertrophy (2017) (0)
Some Thoughts from Your Publisher (2001) (0)
Abstract 16157: Single Measurement of GDF-15 Provides Reliable Prognostication of Stroke and Major Bleeding in Atrial Fibrillation (2014) (0)
Questionable levels of evidence in new atrial fibrillation guidelines? Reply. (2013) (0)
A change of scene: Dan Atar, PhD, MD, FESC. Interview by Emma Wilkinson. (2007) (0)
European Heart Journal-Cardiovascular Pharmacotherapy in 2016: entering a new level of international recognition. (2017) (0)
Rhythm versus rate control in patients with newly diagnosed atrial fibrillation: observations from the GARFIELD-AF registry (2022) (0)
ROUTINE EARLY EPTIFIBATIDE, INFARCT SIZE, AND OUTCOMES IN NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME PATIENTS WITH ELEVATED TROPONIN ON ADMISSION (2012) (0)
Efficacy and safety of dronedarone versus placebo in patients with atrial fibrillation stratified according to renal function: Post hoc analyses of the EURIDIS‐ADONIS trials (2022) (0)
SURGICAL TREATMENT OF FRACTURES OF THE DISTAL FEMUR IN TEENAGERS: OPTIONS, OUTCOMES AND COMPLICATIONS (2008) (0)
Semi-automatic segmentation of myocardium at risk from contrast enhanced SSFP images - validation against manual delineation and SPECT (2015) (0)
Response to the editor (2018) (0)
P3613Clinical outcomes in patients with atrial fibrillation and echocardiographic risk factors for stroke anticoagulated with apixaban or warfarin (2017) (0)
Intensivering av antitrombotisk behandling ved kronisk aterosklerotisk sykdom (2020) (0)
Medikamentell og ventilatorisk behandling ved akutt hjertesvikt (2006) (0)
[New European guidelines for acute myocardial infarction]. (2011) (0)
Contents Vol. 94, 2000 (2001) (0)
Accuracy of quantification of coronary arteriograms with hand-held calipers. A validation study. (1994) (0)
Natriuretic peptide testing for long-term risk assessment following acute ischemic stroke (2009) (0)

This paper list is powered by the following services:

Other Resources About Dan Atar

en.wikipedia.org

What Schools Are Affiliated With Dan Atar?

Dan Atar is affiliated with the following schools:

Dan Atar's Academic­Influence.com Rankings

Why Is Dan Atar Influential?

Dan Atar's Published Works

Published Works

Other Resources About Dan Atar

What Schools Are Affiliated With Dan Atar?

Image Attributions

Dan Atar's AcademicInfluence.com Rankings